TNF and Kawasaki disease: Kawasaki disease is a further autoinflammatory disease primarily involving young children, with substantial risk of coronary artery involvement, which may receive benefit from the use of human-murine chimeric monoclonal anti-TNF-α antibody infliximab in the case of non-responsiveness to the conventional therapies [104].